טוען...
The Role of Protease-Activated Receptor 2 in Hepatocellular Carcinoma after Hepatectomy
Background and Objectives: Protease activated receptor-2 (PAR2) is elevated in a variety of cancers and has been promoted as a potential therapeutic target. However, the clinical and prognostic values of PAR2 in hepatocellular carcinoma (HCC) are poorly characterized. This study aimed to evaluate th...
שמור ב:
| הוצא לאור ב: | Medicina (Kaunas) |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8229727/ https://ncbi.nlm.nih.gov/pubmed/34199695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medicina57060574 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|